Thus, in nasopharyngeal carcinoma, either a reduced BCL6 expression or the presence of a BCL6-SPECC1L fusion, which removes the repressive function of the protein, has been associated with enhanced growth [112]. The gene discussed is BCL6; the disease is nasopharyngeal carcinoma.